Journal article
Incidence of diabetes following ramipril or rosiglitazone withdrawal
- Abstract:
-
OBJECTIVE - To examine the impact of withdrawing rosiglitazone and ramipril medication on diabetes incidence after closeout of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. RESEARCH DESIGN AND METHODS - The 3,366 DREAM subjects at trial end who had not developed diabetes while taking double-blind study medication were transferred to single-blind placebo for 2 to 3months before undergoing an oral glucose tolerance test. Glycemic status was analyzed...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Diabetes Care
- Volume:
- 34
- Issue:
- 6
- Pages:
- 1265-1269
- Publication date:
- 2011-06-01
- DOI:
- EISSN:
-
1935-5548
- ISSN:
-
0149-5992
- Source identifiers:
-
179543
Item Description
- Language:
- English
- Pubs id:
-
pubs:179543
- UUID:
-
uuid:654e3bb9-0397-4651-b1c8-cff38ff1ccce
- Local pid:
- pubs:179543
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2011
If you are the owner of this record, you can report an update to it here: Report update to this record